Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1872]
News [4281]
Articles [400]
Editorials [10]
Conferences [107]
elearning [41]
Changes in mammographic density
Dr Malcom Pike – Memorial Sloan-Kettering Cancer Center, New York, USA
Changes in mammographic density ( Dr Malcom Pike – Memorial Sloan-Kettering Cancer Center, New York, USA )
17 Oct 2011
Symmetrical and asymmetrical stem cell proliferation
Dr Wenjun Guo – Whitehead Institute for Biomedical Research, Cambridge, USA
Symmetrical and asymmetrical stem cell proliferation ( Dr Wenjun Guo – Whitehead Institute for Biomedical Research, Cambridge, USA )
17 Oct 2011
Cancer risk communication
Carol Maddock - Cancer Communications Researcher, Tenovus
Cancer risk communication ( Carol Maddock - Cancer Communications Researcher, Tenovus )
17 Oct 2011
60 years in oncology
Prof Umberto Veronesi - European Institute of Oncology, Milan, Italy
60 years in oncology ( Prof Umberto Veronesi - European Institute of Oncology, Milan, Italy )
6 Oct 2011
Roundup of the EMCC 2011 conference
Prof Gordon McVie - European Institute of Oncology and ecancer
Roundup of the EMCC 2011 conference ( Prof Gordon McVie - European Institute of Oncology and ecancer )
3 Oct 2011
Effects of chemotherpay during pregnancy
Prof Frederic Amant - University Hospitals Leuven, Belgium
Effects of chemotherpay during pregnancy ( Prof Frederic Amant - University Hospitals Leuven, Belgium )
27 Sep 2011
Olaparib extends PFS in women with high-grade serous ovarian cancer
Prof Hilary Calvert - University College London, UK
Olaparib extends PFS in women with high-grade serous ovarian cancer ( Prof Hilary Calvert - University College London, UK )
27 Sep 2011
The BOLERO-2 study confirms everolimus and exemestane in ER/PR+ advanced breast...
Prof José Baselga – Massachusetts General Hospital Cancer Center, USA
The BOLERO-2 study confirms everolimus and exemestane in ER/PR+ advanced breast cancer improves PFS ( Prof José Baselga – Massachusetts General Hospital Cancer Center, USA )
26 Sep 2011
Trastuzumab emtansine, Phase II trial for HER2
Dr Sara Hurvitz - UCLA Santa Monica Hematology Oncology, USA
Trastuzumab emtansine, Phase II trial for HER2 ( Dr Sara Hurvitz - UCLA Santa Monica Hematology Oncology, USA )
25 Sep 2011
Radiotherapy between or during chemo cycles for breast cancer
Dr Indrajit Fernando - Queen Elizabeth Hospital, Birmingham, UK
Radiotherapy between or during chemo cycles for breast cancer ( Dr Indrajit Fernando - Queen Elizabeth Hospital, Birmingham, UK )
25 Sep 2011
Zoledronic acid reduces recurrence of breast cancer
Prof Robert Coleman - Weston Park Hospital, Sheffield, UK
Zoledronic acid reduces recurrence of breast cancer ( Prof Robert Coleman - Weston Park Hospital, Sheffield, UK )
25 Sep 2011
Frequency of biopsies for breast cancer tumours
Dr Linda Lindstrom - Karolinska Institutet, Stockholm, Sweden
Frequency of biopsies for breast cancer tumours ( Dr Linda Lindstrom - Karolinska Institutet, Stockholm, Sweden )
25 Sep 2011

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation